Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models

[Display omitted] Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive type of cancer with an overall survival rate of less than 7–8%, emphasizing the need for novel effective therapeutics against PDAC. However only a fraction of therapeutics which seemed promising in the laboratory en...

Full description

Saved in:

Bibliographic Details
Published in:	Advanced drug delivery reviews Vol. 174; pp. 265 - 293
Main Authors:	Heinrich, Marcel A., Mostafa, Ahmed M.R.H., Morton, Jennifer P., Hawinkels, Lukas J.A.C., Prakash, Jai
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01.07.2021
Subjects:	Animals Bioprinting Carcinoma, Pancreatic Ductal - drug therapy Carcinoma, Pancreatic Ductal - pathology Disease Models, Animal Disease Progression Drug Development - methods Genetically engineered mouse models Humans Mice Mice, Transgenic Models, Biological Pancreatic ductal adenocarcinoma Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - pathology Tumor Microenvironment Tumor-on-chip Bioprinting Genetically engineered mouse models Tumor-on-chip Tumor microenvironment Pancreatic ductal adenocarcinoma
ISSN:	0169-409X, 1872-8294, 1872-8294
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!